Search Results - "Adriaansen, H J"

‘Oversaturation’ of transferrin after intravenous ferric gluconate (FerrlecitR) in haemodialysis patients by Zanen, A. L., Adriaansen, H. J., van Bommel, E. F. H., Posthuma, R., de Jong, G. M. Th

“…Background Chronic haemodialysis causes blood loss and iron-deficiency. This can be corrected with intravenous preparations, e.g. sodium ferric-gluconate…”
Get full text

Persistent polyclonal B-cell lymphocytosis: extensively proliferated CD27+IgM+IgD+ memory B cells with a distinctive immunophenotype by Berkowska, M A, Grosserichter-Wagener, C, Adriaansen, H J, de Ridder, D, Mirani-Oostdijk, K P, Agteresch, H J, Böttcher, S, Orfao, A, van Dongen, J J M, van Zelm, M C

Get full text

Citalopram is a more potent platelet function inhibitor than paroxetine in a case–control study by VAN HOLTEN, T. C., ROEST, M., RIPHAGEN, J., JANSEN, C., NAARDING, P., ADRIAANSEN, H. J., DE GROOT, P. G., REMIJN, J. A.

Get full text

SIHONSCORE: a scoring system for external quality control of leukaemia/lymphoma immunophenotyping measuring all analytical phases of laboratory performance by Kluin‐Nelemans, J. C., Van Wering, E. R., Van Der Schoot, C. E., Adriaansen, H. J., Van't Veer, M. B., Van Dongen, J. J. M., Gratama, J. W.

“…For the diagnosis of leukaemia and leukaemic lymphoma, clinicians frequently have to rely on the results of immunophenotyping. To improve the quality of these…”
Get full text

Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction by van Dongen, J J, Breit, T M, Adriaansen, H J, Beishuizen, A, Hooijkaas, H

“…Detection of minimal residual disease (MRD) can be useful for adaptation or stratification of treatment in acute leukemia patients and may finally result in…”
Get more information

Cytoplasmic Expression of the CD3 Antigen as a Diagnostic Marker for Immature T-Cell Malignancies by Dongen, J.J.M. van, Krissansen, G.W., Wolvers-Tettero, I.L.M., Comans-Bitter, W.M., Adriaansen, H.J., Hooijkaas, H., Wering, E.R. van, Terhorst, C.

“…The expression of cytoplasmic CD3 (CyCD3) was analyzed in 45 leukemias, five thymus cell samples, five peripheral blood (PB) samples, and ten cell lines. All T…”
Get full text

Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression by ADRIAANSEN, H. J, TE BOEKHORST, P. A. W, HAGEMEIJER, A. M, VAN DER SCHOOT, C. E, DELWEL, H. R, VAN DONGEN, J. J. M

“…Extensive immunologic marker analysis was performed to characterize the various leukemic cell populations in eight patients with inv(16)(p13q22) in association…”
Get full text

High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia by SONNEVELD, P, NOOTER, K, BURHOUTHS, J. T. M, HERWEIJER, H, ADRIAANSEN, H. J, VAN DONGEN, J. J. M

“…Chronic lymphocytic leukemia (CLL) is characterized by an often indolent course with a poor therapeutic response at advanced stage. We investigated the…”
Get full text

T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level by van Dongen, JJ, Quertermous, T, Bartram, CR, Gold, DP, Wolvers-Tettero, IL, Comans-Bitter, WM, Hooijkaas, H, Adriaansen, HJ, de Klein, A, Raghavachar, A

“…T cell acute lymphoblastic leukemias (T-ALL) can be regarded as the malignant counterparts of cells in various T cell differentiation stages. To study the…”
Get full text

Terminal Deoxynucleotidyl Transferase (TdT)-Positive Cells in Cerebrospinal Fluid and Development of Overt CNS Leukemia: A 5-Year Follow-up Study in 113 Children With a TdT-Positive Leukemia or Non-Hodgkin’s Lymphoma by Hooijkaas, Herbert, Hahlen, Karel, Adriaansen, Henk J., Dekker, Ina, van Zanen, George E., van Dongen, Jacques J.M.

“…We investigated whether an indirect nuclear terminal deoxynucleotidyl transferase (TdT) immunofluorescence (IF) assay on single cells present in the…”
Get full text

Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease by Adriaansen, H J, van Dongen, J J, Kappers-Klunne, M C, Hählen, K, van 't Veer, M B, Wijdenes-de Bresser, J H, Holdrinet, A C, Harthoorn-Lasthuizen, E J, Abels, J, Hooijkaas, H

“…A series of 60 acute nonlymphocytic leukemias (ANLL) was analyzed for the expression of terminal deoxynucleotidyl transferase (TdT). The detected TdT+ cells…”
Get more information

Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers by Adriaansen, H J, Jacobs, B C, Kappers-Klunne, M C, Hählen, K, Hooijkaas, H, van Dongen, J J

“…In the majority of patients with acute myeloid leukemia (AML) immature leukemic subpopulations expressing myeloid markers and terminal deoxynucleotidyl…”
Get more information

Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis by Knulst, A C, Adriaansen, H J, Hählen, K, Stigter, J C, van den Beemd, M W, Hagemeijer, A, van Dongen, J J, Hooijkaas, H

“…During a period of 9 years, we performed immunological marker analysis in 164 children with acute lymphoblastic leukemia. In four children the diagnosis acute…”
Get more information

Ultrasound examination of pathological cervical lymph nodes in patients with non-Hodgkin's lymphoma and Hodgkin's disease by Gerrits, C J, van Overhagen, H, van Lom, K, Adriaansen, H J, Löwenberg, B

“…The choice of treatment of malignant lymphoma may vary considerably and is mainly determined by the pathology and clinical stage. Ultrasonography is currently…”
Get more information

TdT positive B-cell acute lymphoblastic leukaemia (B-ALL) without Burkitt characteristics by Michiels, J J, Adriaansen, H J, Hagemeijer, A, Hooijkaas, H, van Dongen, J J, Abels, J

“…The leukaemic cells in a 23-year-old man were small to medium-sized lymphoblasts with no cytoplasmic vacuoles and negative with PAS as well with peroxidase and…”
Get more information

The appearance of transferrin receptors on cultured human cytotrophoblast and in vitro-formed syncytiotrophoblast by Bierings, M B, Adriaansen, H J, Van Dijk, J P

“…Using trypsinization and Percoll gradient centrifugation, mononuclear cell populations were prepared from human term placentae. These populations consist…”
Get more information

Bronchoalveolar lavage in extrapulmonary sarcoidosis by Hoogsteden, H C, van Dongen, J J, Adriaansen, H J, Hooijkaas, H, Delahaye, M, Hop, W, Hilvering, C

“…Twenty-one patients presenting with extrapulmonary sarcoidosis, 20 patients with pulmonary sarcoidosis, and 12 healthy volunteers were investigated. They were…”
Get more information

Richter's syndrome with identical immunoglobulin gene rearrangements in the chronic lymphocytic leukemia and the supervening non-Hodgkin lymphoma by Michiels, J J, van Dongen, J J, Hagemeijer, A, Sonneveld, P, Ploemacher, R E, Adriaansen, H J, van der Kwast, T H, Brederoo, P, Abels, J

“…In a patient who developed Richter's syndrome, complex cytogenetic abnormalities of the centroblastic non-Hodgkin lymphoma (NHL) was associated with…”
Get more information

Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial by Van Doorn, S, Joosten, L P T, Kohlen, B T G, Nierman, M C, Koek, H L, Hemels, M E W, Huisman, M V, Kruip, M, Faber, L M, Wiersma, N M, Buding, W F, Adriaansen, H J, Rutten, F H, Geersing, G J

“…Abstract Background Bleeding remains an important complication in anticoagulated patients with atrial fibrillation (AF). Hereto, multiple scores have been…”
Get full text

Quality of life when switching from a vitamin K antagonist to non-vitamin K antagonist oral anticoagulation in frail older patients with atrial fibrillation by Van Doorn, S, Joosten, L P T, Kohlen, B T G, Nierman, M C, Koek, H L, Hemels, M E W, Huisman, M V, Kruip, M, Faber, L M, Wiersma, N M, Buding, W F, Adriaansen, H J, Rutten, F H, Geersing, G J

“…Abstract Background Many older patients with atrial fibrillation (AF) are frail, putting them at high risk of adverse outcomes including mortality,…”
Get full text